Back to top

Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop

Replimune Group, Inc. (NASDAQ: REPL) is facing a federal securities lawsuit alleging that the company misled investors about the regulatory strengt...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Replimune Group, Inc. (REPL)